Plerixafor Used in a “Just in Time” Fashion Allows Timely Autologous Hematopoietic Cell Transplant (HCT) in Patients Who Are at High Risk for Inadequate Apheresis

Biology of Blood and Marrow Transplantation - Netherlands

doi 10.1016/j.bbmt.2015.11.454